Skip to main content

Microdose Presents Psychedelic Capital - A Virtual Investment Conference Highlighting Prominent Industry Players

By: Issuewire
Psychedelic Capital Sept 30th

Microdose Psychedelic Insights, in partnership with The Conscious Fund, is pleased to announce the next edition of Psychedelic Capital taking place on September 30th, 2020 at 1PM EST.

Toronto, Sep 29, 2020 (Issuewire.com) - Psychedelic Capital provides investment grade information for the nascent psychedelic sector and presents a curated group of CEOs, financial experts, thought leaders and investment luminaries from around the globe. You may find free tickets, compliments of our sponsors, by clicking this link.

This month's conference features expert presentations from our sponsors, including Doug Dryslade, the new CEO of Cybin Corp., Dr. Jeffrey Becker and Gregg Peterson of Bexson Biomedical, and Dr. Joseph Tucker, CEO from MagicMed Industries. Additional speakers include "technodelic" videogame designer, Robin Arnott, Joël Brierre, founder of Kaivalya Collective, Danilo Tomanovic, president of ML Deep Dive, Ronan Levy, executive chairman of Field Trip Health, international women's rights activist Lynsey Bourke, Nikolai Vassev, founder of Mindleap Health and Tom Galea, director and cofounder of Lumenate.

This online event programming is dedicated to providing investment grade information for the nascent psychedelic sector and presents a curated group of CEOs, financial experts, thought leaders and investment luminaries from around the globe. Previous events have featured presentations by influential firms in the burgeoning psychedelic sector. Presentations are 30 minutes in length, with 10 minutes always allocated to a one-on-one Q&A session with the audience. Psychedelic Capital features the top companies, latest IPOs, newest opportunities and deepest insights into the emerging psychedelic space. 

As the psychedelic renaissance continues its remarkable progress, the need for deeper insights into the investment landscape is more important than ever before. This monthly virtual conference is aimed at providing quality information about psychedelics from industry experts and thought leaders. To register for your free tickets please click here.

 

About Microdose Psychedelic Insights

Microdose Psychedelic Insights aims to unlock the potential of psychedelics through Industry events, market intelligence, original, evidence-based content, strategy and community. We enable and empower society at large to make better, more mindful decisions about psychedelics and its intersection with healthcare, medicine and personal growth. We work with the industry's most influential stakeholders, some of the world's best-known brands and an unrivalled network of scientists, researchers, analysts, innovators, investors and advisors.

Psychedelic Capital Sept 30th SpeakersPsychedelic Capital Sep 30th

Media Contact

Microdose Psychedelic Insights


kristina@microdose.buzz

https://microdose.buzz

Source :Microdose Psychedelic Insights

This article was originally published by IssueWire. Read the original article here.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.